Amaranth oil application for coronary heart disease and hypertension

Lipids in Health and Disease

Volumn 6, Issue , 2007, Pages

  Martirosyan, Danik M ^a   Miroshnichenko, Lidia A ^b   Kulakova, Svetlana N ^c   Pogojeva, Ala V ^c   Zoloedov, Vladimir I ^b  

^a Functional Foods Center at D&A Inc   (United States)

^b VORONEZH STATE UNIVERSITY   (Russian Federation)

^c INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOTRIENOL; AMARANTH OIL; CHOLESTANOL; ESTRONE DERIVATIVE; HIGH DENSITY LIPOPROTEIN; LANOSTEROL; LOW DENSITY LIPOPROTEIN; PLACEBO; POTASSIUM ION; SODIUM ION; SQUALENE; STEROL; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID; VEGETABLE OIL; FATTY ACID;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BITTER TASTE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DYSPEPSIA; ERUCTATION; FEMALE; HEARTBURN; HUMAN; HUMORAL IMMUNITY; HYPERTENSION; IMMUNOMODULATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NAUSEA; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; UNPLEASANT AFTERTASTE; UNPLEASANT SENSATION; AMARANTHUS; CELL MEMBRANE; CHEMISTRY; CORONARY ARTERY DISEASE; DIET THERAPY; METABOLISM; MIDDLE AGED; OBESITY; PATHOLOGY;

AMARANTHUS CAUDATUS; GALLUS GALLUS;

ADULT; AGED; AMARANTHUS; CELL MEMBRANE; CORONARY DISEASE; FATTY ACIDS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; PLANT OILS;

EID: 33846535383     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-6-1     Document Type: Article

References (59)

1. Miettinen TA: Detection of changes in human cholesterol metabolism. Ann Clin Res 1970, 2:300-320.
2. Miettinen TA: Serum squalene and methyl sterols as indicators of cholesterol synthesis in vivo. Life Sci 1969, 8:713-721.
3. Kempen HJM, Glatz JFC, Gevers Leuven JA, van der Voort HA, Katan MB: Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J Lipid Res 1988, 29:1149-1155.
4. Miettinen TA, Tilvis RS, Kesäniemi YA: Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990, 131:20-31.
5. Tilvis RS, Miettinen TA: Serum plant sterols and their relation to cholesterol absorption. Am J Clin Nutr 1986, 43:92-97.
6. Miettinen TA, Tilvis RS, Kesäniemi YA: Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men. Metabolism 1989, 38:136-140.
7. Qureshi AA, Lehmann JW, Peterson DM: Amaranth and its oil inhibit cholesterol biosynthesis in 6-week-old female chickens. J Nutr 1996, 126(8):1972-8.
8. Berger A, Gremaud G, Baumgartner M, Rein D, Monnard I, Kratky E, Geiger W, Burri J, Dionisi F, Allan M, Lambelet P: Cholesterol-lowering properties of amaranth grain and oil in hamsters. Int J Vitam Nutr Res 2003, 73:39-47.
9. Martirosyan Danik M, Mnatsakanian Vilen A, Gulxandarian Armen A: AlgunasCaracteristicas Bioquimicas y Biofisicas Del Aceite Extraido De semillas De Cuatro Eppecies De Amarantos (Amaranthus spp.), Journal "Amarantos", agosto, Argentina, ISSN 0327-3989 1994:1-3.
10. Tucker JB: Amaranth: the once and future crop. Bioscience 1986, 36:9-13. 59-60
11. Becker R, Wheeler EL, Lorenz K, Stafford AE, Grosjean OK, Betschart AA, Saunders RM: A composition study of amaranth grain. J Food Sci 1981, 46:1175-1180.
12. Teutonico RA, Knorr D: Amaranth: Composition, properties, and applications of a rediscovered food crop. Food Technol 1985, 39:49-60.
13. Martirosyan DM: Amaranth as a Nutritional Supplement for the Modern Diet. Amaranth Legacy, USA 2001, 14:2-4.
14. Martirosyan DM: Amaranth, Quinoa and Lentils as a Source of Modern Diet and Functional Foods. In Book: Non-Traditional Natural Resources, Innovation Technologies and Products Moscow, Russia, Russian Academy of Natural Sciences; 2003:91-100.
15. Bressani R: The proteins of grain amaranth. Food Rev Int 1989, 5:13-38.
16. Lehman J: Proteins of grain amaranth. Legacy 2:3-6 Amer. Amaranth Inst 1989.
17. Kadoshnikov Sergey I, Kadoshnikova Irina G, Martirosyan Danik M: Investigation of Fractional Composition of the Protein in Amaranth. In Book "Non-Traditional Natural Resources, Innovation Technologies and Products" Issue 12 Moscow, Russian Academy of Natural Sciences, Moscow; 2005:81-104.
18. Lyon CK, Becker R: Extraction and refining of oil from amaranth seed. J Am Oil Chem Soc 1987, 64:233-236.
19. Yorge Soriano Santos: Chemical Characteristics of Amaranth oil. Ciencia 1992, 45:113-119.
20. Martirosyan Danik M, Mnatsakanyan Vilen A, Gyulchandaryan Armen A: Biochemical and Biophysical characteristics of the four species of Amaranth. Journal Amarantos, Argentina . 1994, August, 1-3
21. Pogojeva AV, Gonor KV, Kulakova SN, Miroshnichenko LA, Martirosyan DM: Effect of Amaranth Oil on Lipid Profile of Patients with Cardiovascular Diseases. In Book Functional Foods for Chronic Diseases Edited by: Martirosyan DM. Dallas, USA; 2006:35-45.
22. Makus DJ, Davis DR: A mid-summer crop for fresh greens or canning - vegetable amaranth. Ark Farm Res 1984.
23. Igbokwe PE, Tiwari SC, Collins JB, Tartt JB, Russell LC: Amaranth - A potential crop for southwestern Mississippi. Res. Report 13 No. 10. Mississippi Agr & Forestry Expt Sta, Mississippi State Univ, Mississippi State 1988.
24. Martirosyan DM, Kadoshnikov SI, Bil' KY, Tchernov IA, Kulikov YA: Carotenoids Accumulation in the Amaranth and its Role in Cancer Prevention. Book: Phytotherapy with Biological Active Substrates on the Basis of Natural Sources, Chernogolovka, Russia 2004:100-112.
25. Martirosyan DM, Kadoshnikov SI, Borsukov PA, Kadoshnikova IG, Agababyan EY, Kamalyan NS, Mnatsakanyan VA: Pharmacological Properties of Amaranth, Legacy. 2003, 14:6-10.
26. Sanchez JMC: Amaranth (Amaranthus spp.) as forage. Proc. Fourth Amaranth Conf, Minnesota Ext. Serv, Minnesota Agr, Univ Minnesota, St Paul 1990.
27. Kadoshnikov SI, Martirosyan DM, Kadoshnikova IG, Tchernov IA: A study on the Silage Use of Plain and Combined Amaranth in Ontogenesis. Legacy 2001, 16(1):4-8.
28. Sleugha Byron B, Mooreb Kenneth J, Brummerb E Charles, Knappb Allan D, Russellb James, Gibsonb Lance: Forage Nutritive Value of Various Amaranth Species at Different Harvest Dates. Crop Science 2001, 41:466-472.
29. Martirosyan DM, Sekoyan ES, Kadoshnikov SI, Kadoshnikova IG, Sargsyan AV, Parsadanyan RA, Taskov KV: Amaranth as a Sourse of Functional Foods. In The 2004 International Conference Proceeding Edited by: Martirosyan DM, Yensen NP. Dallas, USA:68-73. November 16-17, 2005
30. Martirosyan DM, Sargsyan AV, Parsadanyan RA: Functional Food for the Prevention of Hypertension. In Book Functional Foods for Cardiovascular Diseases Edited by: Martirosyan DM. Dallas, USA; 2005:200-205.
31. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: the Hypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT). JAMA 2002, 288:2981-2997.
32. Hata , Yoshiya : A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. American Journal of Clinical Nutrition 1996, 65:767-71.
33. He HP, Cai Y, Sun M, Corke H: Extraction and purification of squalene from amaranthus grain. J Agric Food Chem 50(2):368-72. 2002 Jan 16
34. Whelton , Paul K: Effects of oral potassium on blood pressure. Journal of the American Medical Association 277:1624-32. 1997 May 28
35. Betschart AA, Irving DW, Shepherd AD, Saunders RM: Amaranthus cruentus: milling characteristics, distribution of nutrients within seed components, and the effects of temperature on nutritional quality. J Food Sci 1981, 46:1181-1187.
36. Lorenz K, Hwang YS: Lipids in amaranths. Nutrition Reports International 1985, 31:83-89.
37. Yanez E, Zacarias I, Granger D, Vasquez M, Estevez AM: Chemical and nutritional characterization of amaranthus (Amaranthus cruentus)]. Arch Latinoam Nutr 1994, 44(1):57-62.
38. Czerwinski J, Bartnikowska E, Leontowicz H, Lange E, Leontowicz M, Katrich E, Trakhtenberg S, Gorinstein S: Oat (Avena sativa L.) and amaranth (Amaranthus hypochondriacus) meals positively affect plasma lipid profile in rats fed cholesterol-containing diets. J Nutr Biochem 2004, 15(10):622-9.
39. Gregory S, Kelly ND: Squalene and Its Potential Clinical Uses. Altern Med Rev 1999, 4(1):29-36.
40. Tilvis R, Kovanen PT, Miettinen TA: Metabolism of squalene in human fat cells. Demonstration of a two-pool system. J Biol Chem 1982, 257:10300-10305.
41. Cobiac , Lynne : Effects of dietary sodium restriction and fish oil supplements on blood pressure in the elderly. Clinical and Experimental Pharmacology and Physiology 1991, 18:265-68.
42. Morris , Clare Martha: Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993, 88(2):523-33.
43. Layne KS, Goh YK, Jumpsen JA: Normal subjects consuming physiological levels of 18:3(n-3) and 20:5(n-3) from flaxseed or fish oils have characteristic differences in plasma lipid and lipoprotein fatty acid levels. J Nutr 1996, 126:2130-40.
44. De Lorgeril M, Salen P, Martin J-L: Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction. Final report of the Lyon Diety Heart Study. Circulation 1999, 99:779-85.
45. De Lorgeril M, Salen P, Martin J-L: Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction. Final report of the Lyon Diety Heart Study. Circulation 1999, 99:779-85.
46. Rice RD: Mediterranean diet. Lancet 1994, 345:893-4.
47. Zoblkova ZS, Shcherbakova SA, Pogozheva AV, Dmitrievskaia MN, Gonor KV, Mal'tsev GIu: The effect of diet with the sour-milk product enriched with amaranth on parameters of antioxigen protection at patients with a cardiovascular pathology. Vopr Pitan 2004, 73(5):21-3.
48. Kwiterovich PO Jr: The antiatherogenic role of high-density lipoprotein cholesterol. Am J Cardiol 1998, 82:Q13-21.
49. Gotto AM Jr: Triglyceride as a risk factor for coronary artery disease. Am J Cardiol 1998, 82:Q22-5.
50. Miettinen TA, Vanhanen H: Serum concentration and metabolism of cholesterol during rapeseed oil and squalene feeding. Am J Clin Nutr 1994, 59:356-363.
51. Ferrara , Aldo L: Olive oil and reduced need for antihypertensive medications. Archives of Internal Medicine 160:837-42. March 27, 2000
52. Briedis V, Povilaitytë V, Kazlauskas S, Venskutonis PR: Polyphenols and anthocyanins in fruits, grapes wines, and avaluation of their antioxidant activity, Medicina 2003, 39(2):104-111.
53. Kim Hye Kyung, Kim Mi Jeong, Cho Hong Yon, Kim Eun-Ki, Shin Dong Hoon: Antioxidative and anti-diabetic effects of amaranth (Amaranthus esculantus) in streptozotocin-induced diabetic rats. Cell Biochem Funct 2006, 24(3):1.
54. Hogan CM, Hammer SM: Host determinants in HIV infection and disease. Part 1: cellular and humoral immune responses. Ann Intern Med 2001, 134:761-776.
55. Pilgrim AK, Pantaleo G, Cohen OJ, Fink LM, Zhou JY, Zhou JT, Bolognesi DP, Fauci AS, Montefiori DC: Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. J Infect Dis 1997, 176:924-932.
56. Ross HA, Rodrigo AG: Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration. J Virol 2002, 76:11715-11720.
57. Geffin R, Hutto C, Andrew C, Scott GB: A longitudinal assessment of autologous neutralizing antibodies in children perinatally infected with human immunodeficiency virus type 1. Virology 2003, 310:207-215.
58. Hutto C, Zhou Y, He J, Geffin R, Hill M, Scott W, Wood C: Longitudinal studies of viral sequence, viral phenotype, and immunologic parameters of human immunodeficiency virus type 1 infection in perinatally infected twins with discordant disease courses. J Virol 1996, 70:3589-3598.
59. Ostlund RE Jr, Lin X: Regulation of cholesterol absorption by phytosterols. Curr Atheroscler Rep 2006, 8(6):487-91.